Lv51
936 积分 2025-04-29 加入
Rocbrutinib, a Highly Selective Fourth-Generation Covalent and Noncovalent BTK Inhibitor, in R/R Non-GCB DLBCL: Efficacy and Safety from a Phase I Study
6小时前
已完结
MARCHF6 orchestrates hepatic lipid homeostasis by targeting SREBP1 for ER-associated degradation
27天前
已完结
Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling
28天前
已完结
A brain-to-gut signal controls intestinal fat absorption
1个月前
已关闭
A brain-to-gut signal controls intestinal fat absorption
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
2个月前
已完结
Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction‐Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH Resolution
2个月前
已关闭
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update
3个月前
已完结
RYK is a GPNMB receptor that drives MASH
3个月前
已完结
RYK is a GPNMB receptor that drives MASH
3个月前
已完结
皖公网安备34019202002308
